Cleared Special

K181179 - BrainScope One (FDA 510(k) Clearance)

May 2018
Decision
16d
Days
Class 2
Risk

K181179 is an FDA 510(k) clearance for the BrainScope One. This device is classified as a Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid (Class II - Special Controls, product code PIW).

Submitted by Brainscope Company, Inc. (Bethesda, US). The FDA issued a Cleared decision on May 18, 2018, 16 days after receiving the submission on May 2, 2018.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1450. A Prescription Device That Uses A Patient¿s Electroencephalograph (eeg) To Provide An Interpretation Of The Structural Condition Of The Patient¿s Brain In The Setting Of Trauma. The Brain Injury Adjunctive Interpretive Eeg Assessment Aid Is For Use As An Adjunct To Standard Clinical Practice Only As An Assessment Aid For A Medical Condition For Which There Exists Other Valid Methods Of Diagnosis..

Submission Details

510(k) Number K181179 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2018
Decision Date May 18, 2018
Days to Decision 16 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PIW - Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1450
Definition A Prescription Device That Uses A Patient¿s Electroencephalograph (eeg) To Provide An Interpretation Of The Structural Condition Of The Patient¿s Brain In The Setting Of Trauma. The Brain Injury Adjunctive Interpretive Eeg Assessment Aid Is For Use As An Adjunct To Standard Clinical Practice Only As An Assessment Aid For A Medical Condition For Which There Exists Other Valid Methods Of Diagnosis.